BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 27398162)

  • 1. Development and validation a radiomics nomogram for predicting thymidylate synthase status in hepatocellular carcinoma based on Gd-DTPA contrast enhanced MRI.
    Ding Z; Wu Y; Fang G; Lin Z; Lin K; Fu J; Huang Q; Tang Y; You W; Liu J; Zeng Y
    BMC Cancer; 2023 Oct; 23(1):991. PubMed ID: 37848807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers.
    Marin JJG; Monte MJ; Macias RIR; Romero MR; Herraez E; Asensio M; Ortiz-Rivero S; Cives-Losada C; Di Giacomo S; Gonzalez-Gallego J; Mauriz JL; Efferth T; Briz O
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma.
    Alonso-Peña M; Sanchez-Martin A; Sanchon-Sanchez P; Soto-Muñiz M; Espinosa-Escudero R; Marin JJG
    Cancer Drug Resist; 2019; 2(3):680-709. PubMed ID: 35582588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The implications of ABCC3 in cancer drug resistance: can we use it as a therapeutic target?
    Ramírez-Cosmes A; Reyes-Jiménez E; Zertuche-Martínez C; Hernández-Hernández CA; García-Román R; Romero-Díaz RI; Manuel-Martínez AE; Elizarrarás-Rivas J; Vásquez-Garzón VR
    Am J Cancer Res; 2021; 11(9):4127-4140. PubMed ID: 34659880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma.
    Wang M; Yu F; Chen X; Li P; Wang K
    Mol Ther Nucleic Acids; 2020 Sep; 21():13-27. PubMed ID: 32505000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport-Mediated Oxaliplatin Resistance Associated with Endogenous Overexpression of MRP2 in Caco-2 and PANC-1 Cells.
    Biswas R; Bugde P; He J; Merien F; Lu J; Liu DX; Myint K; Liu J; McKeage M; Li Y
    Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31500349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge.
    Nedeljković M; Damjanović A
    Cells; 2019 Aug; 8(9):. PubMed ID: 31443516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing MRP1-4 genes by RNA interference enhances sensitivity of human hepatoma cells to chemotherapy.
    Su Z; Liu G; Fang T; Wang Y; Zhang H; Yang S; Wei J; Lv Z; Tan L; Liu J
    Am J Transl Res; 2016; 8(6):2790-802. PubMed ID: 27398162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of extracellular signal-regulated kinase 1/2 activity in P-glycoprotein-mediated multidrug resistant hepatocellular carcinoma cells.
    Yan F; Wang XM; Pan C; Ma QM
    World J Gastroenterol; 2009 Mar; 15(12):1443-51. PubMed ID: 19322916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance.
    Li G; Chen X; Wang Q; Xu Z; Zhang W; Ye L
    J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):173-5. PubMed ID: 17497289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance of hepatoma cells induced by ATP‑binding cassette transporter G2 by reducing intracellular drug concentration.
    Li Y; Ding B; Liu J; Li X; He C; Wang J; Liu L
    Exp Ther Med; 2023 Mar; 25(3):124. PubMed ID: 36845945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
    Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEK inhibitor enhances sensitivity to chemotherapeutic drugs in multidrug resistant hepatocellular carcinoma cells.
    Meng Q; He X; Xie G; Tian Q; Shu X; Li J; Xiao Y
    Oncol Lett; 2017 Sep; 14(3):3089-3095. PubMed ID: 28928846
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.